A carregar...

Lisinopril pharmacokinetics in chronic renal failure.

1. Lisinopril, a new orally active angiotensin converting enzyme inhibitor, was given to eight patients with stable chronic renal failure, in a dose of 5 mg 24 h-1 for 1 week. Creatinine clearance of the subjects ranged from 0.22 to 1.11 ml s-1. Lisinopril pharmacokinetics were studied over 8 days....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Jackson, B, Cubela, R B, Conway, E L, Johnston, C I
Formato: Artigo
Idioma:Inglês
Publicado em: 1988
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1386449/
https://ncbi.nlm.nih.gov/pubmed/2849471
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!